Back to Agenda
International Pharmacovigilance
Session Chair(s)
Esteban Herrero-Martinez, PhD
Director Regulatory Policy and Intelligence, Novartis Pharmaceuticals UK Limited, United Kingdom
Pharmacovigilance is of increasing focus and importance internationally. Although welcome, huge variations in approach, legislative maturity, resource and fast-moving change are a challenge for all. We all have a responsibility to support development of effective pharmacovigilance systems globally to protect patients and support medicine delivery. With multiple activities worldwide and scarce resources, important key stakeholders must understand each other’s activities and support each other to achieve the same ultimate objectives.
Speaker(s)
Panel Discussion
Amr Saad
Former Associate Minister of Health for Pharmaceutical Affairs, Founder, The Egyptian Pharmacovigilance Center (EPVC) , Egypt
Panel Discussion
Bahija Gouimi
Founder, AMAL, Morocco
Panel Discussion
Raj Long, Med, MSc
Deputy Director, Safety and Pharmacovigilance, Bill and Melinda Gates Foundation, United Kingdom
Panel Discussion
Emer Cooke, MBA
Executive Director, European Medicines Agency, Netherlands
Panel Discussion
June Raine, MD, MSc, FRCP
Chief Executive, Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Panel Discussion
Sue Rees, MS
Director , Sue Rees Consultancy Ltd, United Kingdom
Panel Discussion
Xavier Kurz, MD, PhD, MSc
Head of Data Analytics Workstream, European Medicines Agency, Netherlands
Have an account?